A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine. The findings support further development of the drug candidate for treating and preventing current coronavirus infections and potential future epidemic outbreaks.
Coronaviruses are a genetically diverse family of viruses that infect birds and mammals, with most coronavirus strains limited to infecting only certain hosts. Human coronaviruses, for example, cause up to 30 percent of common colds.
In the last 15 years, however, coronaviruses have demonstrated their ability to jump into new species. Zoonotic (animal) coronaviruses have infected humans, causing severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), severe diseases with high mortality rates ranging from 10 percent for SARS to 40 percent for MERS. The MERS-coronavirus continues to cause new infections in the Middle East.
“There’s a real concern that the MERS coronavirus could escape broadly when millions of people visit Saudi Arabia for the Hajj,” said Mark Denison, M.D., Craig-Weaver Professor of Pediatrics and professor of Pathology, Microbiology and Immunology at Vanderbilt University School of Medicine.
But to date, there has been no effective antiviral drug for any known coronavirus, Denison noted.
Denison and his team at Vanderbilt have studied the basic biology of coronaviruses for more than 20 years. In an effort to find chemical tools that would allow them to probe viral replication, graduate student Brett Case screened a series of compounds selected and provided by Gilead Sciences.
Case demonstrated that one of the compounds was highly active against coronaviruses in cultured cells. The finding was a surprise, Denison said, because compounds in the same class (nucleoside analogs) have normally failed to inhibit coronavirus replication.
The compound, called GS-5734, is currently in clinical development for treatment of Ebola virus disease.
Denison’s longtime collaborator Ralph Baric, Ph.D., at the University of North Carolina and his team demonstrated that GS-5734 inhibits SARS-coronavirus and MERS-coronavirus replication in multiple in vitro systems, including cultures of primary human airway epithelial cells, which are the cells infected by respiratory coronaviruses.
The researchers also showed that GS-5734 was effective against a circulating human coronavirus, bat coronaviruses, and bat coronaviruses that are considered “prepandemic” because they can infect cultured human cells.
Using a mouse model of SARS, the investigators demonstrated that both prophylactic (before infection) and early therapeutic (soon after infection) administration of GS-5734 reduced viral load in the lungs and improved respiratory functions.
“This compound shows broad activity against a variety of human and animal coronaviruses and represents an exciting potential therapeutic for a family of viruses prone to emergence from animal reservoirs,” Denison said.
Denison and his team at Vanderbilt will continue to use the compound “as a probe to try to understand the biology of the virus, how and why this drug works, and to identify new targets for inhibiting coronaviruses,” he said.
“This is an exciting example of how pursuing fundamental research to understand the mechanisms of virus replication and pathogenesis can lead to an important compound with therapeutic potential.”
The Latest on: Coronaviruses
[google_news title=”” keyword=”coronaviruses” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Free COVID-19 Tests: How to Order More At-Home Kits From the Postal Serviceon September 21, 2023 at 6:15 pm
The US Postal Service on Wednesday said it will again start shipping free COVID tests to homes across the country. The new at-home tests are made possible by a $600 million investment from the White ...
- Think you might have COVID-19? Where to find free tests in North Carolinaon September 21, 2023 at 4:44 pm
NCDHHS also has partnered with Community Access Points to provide at-home test kits for free pick up. If you visit the state health department website, you can enter your ZIP code online and find a ...
- No, COVID-19 vaccines were not declared biological weapons in Florida | Fact checkon September 21, 2023 at 1:38 pm
The broadcast featured in the post discusses a letter approved by Republicans in a single county in Florida. No official action has been taken.
- Booking a COVID-19 vaccine? Some are reporting canceled appointments or insurance issueson September 21, 2023 at 1:06 pm
Some people seeking the newest COVID-19 vaccine are running into high demand, insurance headaches and supply delays coast to coast. Millions of the newly formulated vaccines have shipped out since the ...
- COVID-19 Worries Rise Among Americans: Pollon September 21, 2023 at 11:12 am
The rate of pessimism about the coronavirus pandemic is the highest reported in over a year, according to Gallup.
- Get free at-home COVID-19 tests in the mail again. Here's what you need to know.on September 21, 2023 at 10:54 am
The Biden Administration announced that free at-home COVID-19 tests would again be available to order on5. Here's how to order.
- Here's everything Arizonans need to know about getting free at-home COVID-19 testson September 21, 2023 at 9:42 am
As winter approaches and COVID-19 hospitalizations surge, free at-home tests will be available to order again beginning Sept. 25.
- Insurance and supply issues hamper this year's commercialized Covid-19 vaccine campaignon September 21, 2023 at 8:43 am
"COVID vaccines are covered at no cost at any in-network pharmacy or doctor's office for Cigna Healthcare customers. If a Cigna customer believes their COVID vaccine claim was denied incorrectly, we ...
- US households will be able to order more free Covid-19 tests starting Mondayon September 20, 2023 at 7:26 pm
The US government will relaunch a program to provide free Covid-19 tests to Americans, US Department of Health and Human Services Secretary Xavier Becerra said Wednesday.
- New Covid-19 Vaccines Are Here. What to Know About Fall Shots.on September 20, 2023 at 1:50 pm
Americans are starting to roll up their sleeves for shots to stem the expected tide of respiratory infections this fall, including the latest Covid-19 subvariants.
via Google News and Bing News